Submitted by Anonymous (not verified) on 20 November 2023 - 12:22
Human medicines European public assessment report (EPAR): Tagrisso, osimertinib, Carcinoma, Non-Small-Cell Lung, Date of authorisation: 01/02/2016, Revision: 19, Status: Authorised
Source: